Can terbutaline be used safely in patients with hepatic impairment and what adjustments or monitoring strategies are necessary for ensuring its safe administration?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Terbutaline use in hepatic impairment requires caution. Dose adjustments aren’t typically specified, but monitoring liver function tests is advisable to avoid toxicity.
For patients with hepatic impairment, careful monitoring of liver enzymes is necessary when administering terbutaline, as dose adjustments may be required based on liver function.
In hepatic impairment, terbutaline should be used with caution. Regular monitoring of liver function is essential, and dosage may need to be adjusted based on enzyme levels.